SpliceBio has dosed the first patient in the Part B dose-expansion portion of its phase 1/2 ASTRA clinical trial ( ...

Unlike animals, plants generate most organs after embryogenesis through stem cell–driven meristems, enabling lifelong growth ...

Plant regeneration relies on a delicate balance between stem cell renewal and differentiation, yet the evolutionary origin ...

A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...

In a UC Irvine office, Dorota Skowronska-Krawczyk studies a video that has changed her view of a deep-sea legend. “You see it ...

Diorasis Therapeutics, a Boston-based biotechnology company developing durable gene therapies for glaucoma and other ophthalmic diseases, today announced the appointment of Richard A. Kresch, MD, to ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that dosing is complete in ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

The conservation of genome regulatory elements over long periods of evolution is not limited to vertebrates, as previously ...

Inducible promoters provide remarkable utility when sustained transgene expression compromises plant development or agronomic performance.

Collaboration will combine Lexeo expertise in cardiac genetic medicine with Johnson & Johnson’s expertise in cardiovascular therapeutics and ...

A new study from Northwestern University is reshaping how scientists think about brain evolution. The research suggests that ...